Global Intravenous Treatment Market Growth 2025-2031

April 2025 | 97 pages | ID: G93682B02CBAEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Medical Vacuum Regulator market size is predicted to grow from US$ 166 million in 2025 to US$ 235 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.

Medical Vacuum Regulator is a medical device that converts the high-pressure vacuum that is supplied by the hospitals central vacuum system to a safe level for use on a patient.

The vacuum regulator is used to measure and adjust the vacuum level within the context of medical suction. It enables to drain substances out of the patient’s body during surgical procedures. The vacuum regulator should be connected to a vacuum source on the wall either using a direct probe or a rail mounting system. It should be associated with a collection jar and a suction hose.

Global Medical Vacuum Regulator key players include Ohio Medical, Amico, Precision Medical, Air Liquid Healthcare, Integral, etc. Global top five manufacturers hold a share about 35%.

North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, having a total share about 55 percent.

In terms of product, Analog Vacuum Regulator is the largest segment, with a share about 70%. And in terms of application, the largest application is in Clinical, followed by Surgical.

LP Information, Inc. (LPI) ' newest research report, the “Medical Vacuum Regulator Industry Forecast” looks at past sales and reviews total world Medical Vacuum Regulator sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical Vacuum Regulator sales for 2025 through 2031. With Medical Vacuum Regulator sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Vacuum Regulator industry.

This Insight Report provides a comprehensive analysis of the global Medical Vacuum Regulator landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Vacuum Regulator portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Vacuum Regulator market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Vacuum Regulator and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Vacuum Regulator.

This report presents a comprehensive overview, market shares, and growth opportunities of Medical Vacuum Regulator market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Analog Vacuum Regulator
• Digital Vacuum Regulator

Segmentation by Application:

• Clinically
• Surgical

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Ohio Medical
• Amico
• Precision Medical
• Air Liquid Healthcare
• Integral
• Allied Healthcare Products
• Shanghai Amcaremed Technology
• Acare
• Hersill

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical Vacuum Regulator market?

What factors are driving Medical Vacuum Regulator market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Medical Vacuum Regulator market opportunities vary by end market size?

How does Medical Vacuum Regulator break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Intravenous Treatment Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Intravenous Treatment by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Intravenous Treatment by Country/Region, 2020, 2024 & 2031
2.2 Intravenous Treatment Segment by Type
  2.2.1 Peripheral Parenteral Nutrition
  2.2.2 Total Parenteral Nutrition
2.3 Intravenous Treatment Sales by Type
  2.3.1 Global Intravenous Treatment Sales Market Share by Type (2020-2025)
  2.3.2 Global Intravenous Treatment Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Intravenous Treatment Sale Price by Type (2020-2025)
2.4 Intravenous Treatment Segment by Application
  2.4.1 Hospitals and Clinics
  2.4.2 Outpatient clinic
  2.4.3 Home Care
2.5 Intravenous Treatment Sales by Application
  2.5.1 Global Intravenous Treatment Sale Market Share by Application (2020-2025)
  2.5.2 Global Intravenous Treatment Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Intravenous Treatment Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Intravenous Treatment Breakdown Data by Company
  3.1.1 Global Intravenous Treatment Annual Sales by Company (2020-2025)
  3.1.2 Global Intravenous Treatment Sales Market Share by Company (2020-2025)
3.2 Global Intravenous Treatment Annual Revenue by Company (2020-2025)
  3.2.1 Global Intravenous Treatment Revenue by Company (2020-2025)
  3.2.2 Global Intravenous Treatment Revenue Market Share by Company (2020-2025)
3.3 Global Intravenous Treatment Sale Price by Company
3.4 Key Manufacturers Intravenous Treatment Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Intravenous Treatment Product Location Distribution
  3.4.2 Players Intravenous Treatment Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR INTRAVENOUS TREATMENT BY GEOGRAPHIC REGION

4.1 World Historic Intravenous Treatment Market Size by Geographic Region (2020-2025)
  4.1.1 Global Intravenous Treatment Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Intravenous Treatment Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Intravenous Treatment Market Size by Country/Region (2020-2025)
  4.2.1 Global Intravenous Treatment Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Intravenous Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Intravenous Treatment Sales Growth
4.4 APAC Intravenous Treatment Sales Growth
4.5 Europe Intravenous Treatment Sales Growth
4.6 Middle East & Africa Intravenous Treatment Sales Growth

5 AMERICAS

5.1 Americas Intravenous Treatment Sales by Country
  5.1.1 Americas Intravenous Treatment Sales by Country (2020-2025)
  5.1.2 Americas Intravenous Treatment Revenue by Country (2020-2025)
5.2 Americas Intravenous Treatment Sales by Type (2020-2025)
5.3 Americas Intravenous Treatment Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Intravenous Treatment Sales by Region
  6.1.1 APAC Intravenous Treatment Sales by Region (2020-2025)
  6.1.2 APAC Intravenous Treatment Revenue by Region (2020-2025)
6.2 APAC Intravenous Treatment Sales by Type (2020-2025)
6.3 APAC Intravenous Treatment Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Intravenous Treatment by Country
  7.1.1 Europe Intravenous Treatment Sales by Country (2020-2025)
  7.1.2 Europe Intravenous Treatment Revenue by Country (2020-2025)
7.2 Europe Intravenous Treatment Sales by Type (2020-2025)
7.3 Europe Intravenous Treatment Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Intravenous Treatment by Country
  8.1.1 Middle East & Africa Intravenous Treatment Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Intravenous Treatment Revenue by Country (2020-2025)
8.2 Middle East & Africa Intravenous Treatment Sales by Type (2020-2025)
8.3 Middle East & Africa Intravenous Treatment Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravenous Treatment
10.3 Manufacturing Process Analysis of Intravenous Treatment
10.4 Industry Chain Structure of Intravenous Treatment

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Intravenous Treatment Distributors
11.3 Intravenous Treatment Customer

12 WORLD FORECAST REVIEW FOR INTRAVENOUS TREATMENT BY GEOGRAPHIC REGION

12.1 Global Intravenous Treatment Market Size Forecast by Region
  12.1.1 Global Intravenous Treatment Forecast by Region (2026-2031)
  12.1.2 Global Intravenous Treatment Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Intravenous Treatment Forecast by Type (2026-2031)
12.7 Global Intravenous Treatment Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 ICU Medical Inc. (U.S.)
  13.1.1 ICU Medical Inc. (U.S.) Company Information
  13.1.2 ICU Medical Inc. (U.S.) Intravenous Treatment Product Portfolios and Specifications
  13.1.3 ICU Medical Inc. (U.S.) Intravenous Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 ICU Medical Inc. (U.S.) Main Business Overview
  13.1.5 ICU Medical Inc. (U.S.) Latest Developments
13.2 B. Braun Melsungen AG (Germany)
  13.2.1 B. Braun Melsungen AG (Germany) Company Information
  13.2.2 B. Braun Melsungen AG (Germany) Intravenous Treatment Product Portfolios and Specifications
  13.2.3 B. Braun Melsungen AG (Germany) Intravenous Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 B. Braun Melsungen AG (Germany) Main Business Overview
  13.2.5 B. Braun Melsungen AG (Germany) Latest Developments
13.3 Fresenius Kabi AG (Germany)
  13.3.1 Fresenius Kabi AG (Germany) Company Information
  13.3.2 Fresenius Kabi AG (Germany) Intravenous Treatment Product Portfolios and Specifications
  13.3.3 Fresenius Kabi AG (Germany) Intravenous Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Fresenius Kabi AG (Germany) Main Business Overview
  13.3.5 Fresenius Kabi AG (Germany) Latest Developments
13.4 Baxter (U.S.)
  13.4.1 Baxter (U.S.) Company Information
  13.4.2 Baxter (U.S.) Intravenous Treatment Product Portfolios and Specifications
  13.4.3 Baxter (U.S.) Intravenous Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Baxter (U.S.) Main Business Overview
  13.4.5 Baxter (U.S.) Latest Developments
13.5 Amanta Healthcare (India)
  13.5.1 Amanta Healthcare (India) Company Information
  13.5.2 Amanta Healthcare (India) Intravenous Treatment Product Portfolios and Specifications
  13.5.3 Amanta Healthcare (India) Intravenous Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Amanta Healthcare (India) Main Business Overview
  13.5.5 Amanta Healthcare (India) Latest Developments
13.6 Terumo Medical Corporation (Tokyo)
  13.6.1 Terumo Medical Corporation (Tokyo) Company Information
  13.6.2 Terumo Medical Corporation (Tokyo) Intravenous Treatment Product Portfolios and Specifications
  13.6.3 Terumo Medical Corporation (Tokyo) Intravenous Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Terumo Medical Corporation (Tokyo) Main Business Overview
  13.6.5 Terumo Medical Corporation (Tokyo) Latest Developments
13.7 Grifols S.A. (Spain)
  13.7.1 Grifols S.A. (Spain) Company Information
  13.7.2 Grifols S.A. (Spain) Intravenous Treatment Product Portfolios and Specifications
  13.7.3 Grifols S.A. (Spain) Intravenous Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Grifols S.A. (Spain) Main Business Overview
  13.7.5 Grifols S.A. (Spain) Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Intravenous Treatment Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Intravenous Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Peripheral Parenteral Nutrition
Table 4. Major Players of Total Parenteral Nutrition
Table 5. Global Intravenous Treatment Sales by Type (2020-2025) & (K Units)
Table 6. Global Intravenous Treatment Sales Market Share by Type (2020-2025)
Table 7. Global Intravenous Treatment Revenue by Type (2020-2025) & ($ million)
Table 8. Global Intravenous Treatment Revenue Market Share by Type (2020-2025)
Table 9. Global Intravenous Treatment Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Intravenous Treatment Sale by Application (2020-2025) & (K Units)
Table 11. Global Intravenous Treatment Sale Market Share by Application (2020-2025)
Table 12. Global Intravenous Treatment Revenue by Application (2020-2025) & ($ million)
Table 13. Global Intravenous Treatment Revenue Market Share by Application (2020-2025)
Table 14. Global Intravenous Treatment Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Intravenous Treatment Sales by Company (2020-2025) & (K Units)
Table 16. Global Intravenous Treatment Sales Market Share by Company (2020-2025)
Table 17. Global Intravenous Treatment Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Intravenous Treatment Revenue Market Share by Company (2020-2025)
Table 19. Global Intravenous Treatment Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Intravenous Treatment Producing Area Distribution and Sales Area
Table 21. Players Intravenous Treatment Products Offered
Table 22. Intravenous Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Intravenous Treatment Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Intravenous Treatment Sales Market Share Geographic Region (2020-2025)
Table 27. Global Intravenous Treatment Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Intravenous Treatment Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Intravenous Treatment Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Intravenous Treatment Sales Market Share by Country/Region (2020-2025)
Table 31. Global Intravenous Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Intravenous Treatment Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Intravenous Treatment Sales by Country (2020-2025) & (K Units)
Table 34. Americas Intravenous Treatment Sales Market Share by Country (2020-2025)
Table 35. Americas Intravenous Treatment Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Intravenous Treatment Sales by Type (2020-2025) & (K Units)
Table 37. Americas Intravenous Treatment Sales by Application (2020-2025) & (K Units)
Table 38. APAC Intravenous Treatment Sales by Region (2020-2025) & (K Units)
Table 39. APAC Intravenous Treatment Sales Market Share by Region (2020-2025)
Table 40. APAC Intravenous Treatment Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Intravenous Treatment Sales by Type (2020-2025) & (K Units)
Table 42. APAC Intravenous Treatment Sales by Application (2020-2025) & (K Units)
Table 43. Europe Intravenous Treatment Sales by Country (2020-2025) & (K Units)
Table 44. Europe Intravenous Treatment Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Intravenous Treatment Sales by Type (2020-2025) & (K Units)
Table 46. Europe Intravenous Treatment Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Intravenous Treatment Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Intravenous Treatment Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Intravenous Treatment Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Intravenous Treatment Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Intravenous Treatment
Table 52. Key Market Challenges & Risks of Intravenous Treatment
Table 53. Key Industry Trends of Intravenous Treatment
Table 54. Intravenous Treatment Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Intravenous Treatment Distributors List
Table 57. Intravenous Treatment Customer List
Table 58. Global Intravenous Treatment Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Intravenous Treatment Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Intravenous Treatment Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Intravenous Treatment Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Intravenous Treatment Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Intravenous Treatment Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Intravenous Treatment Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Intravenous Treatment Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Intravenous Treatment Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Intravenous Treatment Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Intravenous Treatment Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Intravenous Treatment Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Intravenous Treatment Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Intravenous Treatment Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. ICU Medical Inc. (U.S.) Basic Information, Intravenous Treatment Manufacturing Base, Sales Area and Its Competitors
Table 73. ICU Medical Inc. (U.S.) Intravenous Treatment Product Portfolios and Specifications
Table 74. ICU Medical Inc. (U.S.) Intravenous Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. ICU Medical Inc. (U.S.) Main Business
Table 76. ICU Medical Inc. (U.S.) Latest Developments
Table 77. B. Braun Melsungen AG (Germany) Basic Information, Intravenous Treatment Manufacturing Base, Sales Area and Its Competitors
Table 78. B. Braun Melsungen AG (Germany) Intravenous Treatment Product Portfolios and Specifications
Table 79. B. Braun Melsungen AG (Germany) Intravenous Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. B. Braun Melsungen AG (Germany) Main Business
Table 81. B. Braun Melsungen AG (Germany) Latest Developments
Table 82. Fresenius Kabi AG (Germany) Basic Information, Intravenous Treatment Manufacturing Base, Sales Area and Its Competitors
Table 83. Fresenius Kabi AG (Germany) Intravenous Treatment Product Portfolios and Specifications
Table 84. Fresenius Kabi AG (Germany) Intravenous Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Fresenius Kabi AG (Germany) Main Business
Table 86. Fresenius Kabi AG (Germany) Latest Developments
Table 87. Baxter (U.S.) Basic Information, Intravenous Treatment Manufacturing Base, Sales Area and Its Competitors
Table 88. Baxter (U.S.) Intravenous Treatment Product Portfolios and Specifications
Table 89. Baxter (U.S.) Intravenous Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Baxter (U.S.) Main Business
Table 91. Baxter (U.S.) Latest Developments
Table 92. Amanta Healthcare (India) Basic Information, Intravenous Treatment Manufacturing Base, Sales Area and Its Competitors
Table 93. Amanta Healthcare (India) Intravenous Treatment Product Portfolios and Specifications
Table 94. Amanta Healthcare (India) Intravenous Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Amanta Healthcare (India) Main Business
Table 96. Amanta Healthcare (India) Latest Developments
Table 97. Terumo Medical Corporation (Tokyo) Basic Information, Intravenous Treatment Manufacturing Base, Sales Area and Its Competitors
Table 98. Terumo Medical Corporation (Tokyo) Intravenous Treatment Product Portfolios and Specifications
Table 99. Terumo Medical Corporation (Tokyo) Intravenous Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Terumo Medical Corporation (Tokyo) Main Business
Table 101. Terumo Medical Corporation (Tokyo) Latest Developments
Table 102. Grifols S.A. (Spain) Basic Information, Intravenous Treatment Manufacturing Base, Sales Area and Its Competitors
Table 103. Grifols S.A. (Spain) Intravenous Treatment Product Portfolios and Specifications
Table 104. Grifols S.A. (Spain) Intravenous Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Grifols S.A. (Spain) Main Business
Table 106. Grifols S.A. (Spain) Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Intravenous Treatment
Figure 2. Intravenous Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravenous Treatment Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Intravenous Treatment Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Intravenous Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Intravenous Treatment Sales Market Share by Country/Region (2024)
Figure 10. Intravenous Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Peripheral Parenteral Nutrition
Figure 12. Product Picture of Total Parenteral Nutrition
Figure 13. Global Intravenous Treatment Sales Market Share by Type in 2025
Figure 14. Global Intravenous Treatment Revenue Market Share by Type (2020-2025)
Figure 15. Intravenous Treatment Consumed in Hospitals and Clinics
Figure 16. Global Intravenous Treatment Market: Hospitals and Clinics (2020-2025) & (K Units)
Figure 17. Intravenous Treatment Consumed in Outpatient clinic
Figure 18. Global Intravenous Treatment Market: Outpatient clinic (2020-2025) & (K Units)
Figure 19. Intravenous Treatment Consumed in Home Care
Figure 20. Global Intravenous Treatment Market: Home Care (2020-2025) & (K Units)
Figure 21. Global Intravenous Treatment Sale Market Share by Application (2024)
Figure 22. Global Intravenous Treatment Revenue Market Share by Application in 2025
Figure 23. Intravenous Treatment Sales by Company in 2025 (K Units)
Figure 24. Global Intravenous Treatment Sales Market Share by Company in 2025
Figure 25. Intravenous Treatment Revenue by Company in 2025 ($ millions)
Figure 26. Global Intravenous Treatment Revenue Market Share by Company in 2025
Figure 27. Global Intravenous Treatment Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Intravenous Treatment Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Intravenous Treatment Sales 2020-2025 (K Units)
Figure 30. Americas Intravenous Treatment Revenue 2020-2025 ($ millions)
Figure 31. APAC Intravenous Treatment Sales 2020-2025 (K Units)
Figure 32. APAC Intravenous Treatment Revenue 2020-2025 ($ millions)
Figure 33. Europe Intravenous Treatment Sales 2020-2025 (K Units)
Figure 34. Europe Intravenous Treatment Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Intravenous Treatment Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Intravenous Treatment Revenue 2020-2025 ($ millions)
Figure 37. Americas Intravenous Treatment Sales Market Share by Country in 2025
Figure 38. Americas Intravenous Treatment Revenue Market Share by Country (2020-2025)
Figure 39. Americas Intravenous Treatment Sales Market Share by Type (2020-2025)
Figure 40. Americas Intravenous Treatment Sales Market Share by Application (2020-2025)
Figure 41. United States Intravenous Treatment Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Intravenous Treatment Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Intravenous Treatment Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Intravenous Treatment Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Intravenous Treatment Sales Market Share by Region in 2025
Figure 46. APAC Intravenous Treatment Revenue Market Share by Region (2020-2025)
Figure 47. APAC Intravenous Treatment Sales Market Share by Type (2020-2025)
Figure 48. APAC Intravenous Treatment Sales Market Share by Application (2020-2025)
Figure 49. China Intravenous Treatment Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Intravenous Treatment Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Intravenous Treatment Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Intravenous Treatment Revenue Growth 2020-2025 ($ millions)
Figure 53. India Intravenous Treatment Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Intravenous Treatment Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Intravenous Treatment Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Intravenous Treatment Sales Market Share by Country in 2025
Figure 57. Europe Intravenous Treatment Revenue Market Share by Country (2020-2025)
Figure 58. Europe Intravenous Treatment Sales Market Share by Type (2020-2025)
Figure 59. Europe Intravenous Treatment Sales Market Share by Application (2020-2025)
Figure 60. Germany Intravenous Treatment Revenue Growth 2020-2025 ($ millions)
Figure 61. France Intravenous Treatment Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Intravenous Treatment Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Intravenous Treatment Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Intravenous Treatment Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Intravenous Treatment Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Intravenous Treatment Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Intravenous Treatment Sales Market Share by Application (2020-2025)
Figure 68. Egypt Intravenous Treatment Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Intravenous Treatment Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Intravenous Treatment Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Intravenous Treatment Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Intravenous Treatment Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Intravenous Treatment in 2025
Figure 74. Manufacturing Process Analysis of Intravenous Treatment
Figure 75. Industry Chain Structure of Intravenous Treatment
Figure 76. Channels of Distribution
Figure 77. Global Intravenous Treatment Sales Market Forecast by Region (2026-2031)
Figure 78. Global Intravenous Treatment Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Intravenous Treatment Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Intravenous Treatment Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Intravenous Treatment Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Intravenous Treatment Revenue Market Share Forecast by Application (2026-2031)